Segment reporting (Tables)

9 Months Ended

May 31, 2020

Segment Reporting [Abstract]

Reconciliation of Operating Income (Loss) from Segments to Consolidated

The following table reflects results of operations of the Company's reportable segments (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2020		2019		2020		2019
Sales:
Retail Pharmacy USA	$	27,357	$	26,513	$	80,734	$	78,491
Retail Pharmacy International	1,903		2,776		7,704		8,759
Pharmaceutical Wholesale	5,899		5,865		17,971		17,311
Eliminations1	(527)		(563)		(1,618)		(1,649)
Walgreens Boots Alliance, Inc.	$	34,631	$	34,591	$	104,791	$	102,912
Adjusted Operating income:
Retail Pharmacy USA	$	792	$	1,286	$	3,215	$	4,119
Retail Pharmacy International	(143)		165		133		553
Pharmaceutical Wholesale	271		265		735		710
Eliminations1	—		1		2		1
Walgreens Boots Alliance, Inc.	$	919	$	1,717	$	4,085	$	5,384

¹Eliminations relate to intersegment sales between the Pharmaceutical Wholesale and the Retail Pharmacy International segments.

The following table reconciles adjusted operating income to operating income (in millions):

	Three months ended May 31,				Nine months ended May 31,
	2020		2019		2020		2019
Adjusted operating income	$	919	$	1,717	$	4,085	$	5,384
Impairment of goodwill and intangible assets	(2,001)		—		(2,001)		—
Transformational cost management	(315)		(86)		(524)		(265)
Acquisition-related amortization	(112)		(127)		(348)		(373)
Acquisition-related costs	(68)		(80)		(291)		(228)
LIFO provision	(29)		(29)		(90)		(77)
Store damage and inventory losses1	(75)		—		(75)		—
Store optimization	(10)		(49)		(49)		(99)
Adjustments to equity earnings (loss) in AmerisourceBergen	105		(137)		(47)		(191)
Certain legal and regulatory accruals and settlements	—		(7)		—		(31)
Operating income	$	(1,584)	$	1,203	$	662	$	4,120

¹Store damage and inventory losses as a result of looting in the U.S. during May 2020.